Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Conditions:   Hepatitis B;   HBV;   Hepatitis B, Chronic Interventions:   Drug: Inarigivir soproxil;   Drug: Tenofovir alafenamide fumarate (TAF) Sponsors:   Spring Bank Pharmaceuticals, Inc.;   PRA Health Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials